Table 2. Stroop-Related Neural Activity in Cannabis-Dependent and Healthy-Comparison Individuals: Group Differences and Relationship to Treatment.
|
Peak coordinates |
Statistics |
||||||
|---|---|---|---|---|---|---|---|
| Regions of activation | Laterality | x | y | z | Cluster size | Maximum | Mean |
| Group differences in Stroop-related neural activity at pretreatment baselinea: | |||||||
| Healthy comparisons > cannabis dependent | t | t | |||||
| Ventral Striatum/dorsal striatum/midbrain/subthalamic nucleus/thalamus/amygdala/parahippocampal gyrus | R+L | −12 | −12 | −9 | 674 | −4.56 | −2.45 |
| Dorsolateral prefrontal cortex/middle frontal gyrus | L | −54 | 15 | 39 | 164 | −4.01 | −2.59 |
| Dorsal prefrontal cortex/superior frontal gyrus | R | 24 | 45 | 33 | 147 | −4.33 | −2.69 |
| Anterior insula/superior temporal gyrus | R | 27 | 24 | 0 | 116 | −3.59 | −2.46 |
| Superior and middle temporal gyrus | R | 57 | −51 | 15 | 113 | −3.30 | −2.41 |
| Amygdala/parahippocampal gyrus | R | 30 | 0 | −27 | 96 | −5.08 | −2.71 |
| Dorsolateral prefrontal cortex precentral gyrus/middle frontal gyrus | R | 54 | 6 | 36 | 90 | −3.92 | −2.66 |
| Correlations between pretreatment Stroop-effect related neural activity and cannabis-abstinence measures: | |||||||
| Conjunction of pretreatment Stroop-related neural activity correlation with three within-treatment cannabis-abstinence measuresb | r | r | |||||
| Occipital/lingual gyrus | L | −29 | −66 | 1 | 69 | 0.59 | 0.49 |
| Posterior cingulate cortex | L | −29 | −70 | 16 | 59 | 0.67 | 0.52 |
| Occipital/Lingual Gyrus | R | 33 | −52 | −9 | 51 | 0.67 | 0.50 |
| Dorsal anterior cingulate cortex | R | 3 | 3 | 38 | 22 | 0.59 | 0.49 |
| Cuneus | L | −10 | −74 | 16 | 21 | 0.61 | 0.50 |
| Supramarginal gyrus | R | 61 | −49 | 36 | 20 | 0.55 | 0.49 |
| Pretreatment Stroop-related neural activity correlation with % days cannabis abstinence during 1-year follow-upc | |||||||
| Positive correlations | r | r | |||||
| Posterior cingulate/superior cerebellum | L | −3 | −66 | 9 | 178 | 0.79 | 0.54 |
| Occipital/fusiform gyrus | L | −24 | −90 | −15 | 120 | 0.78 | 0.57 |
| Occipital/fusiform gyrus | R | 42 | −78 | 0 | 119 | 0.73 | 0.55 |
| Ventral striatum/perigenual/subgenual anterior cingulate | L | −6 | 30 | 12 | 119 | 0.82 | 0.55 |
| Superior temporal/lateral orbitofrontal/inferior frontal gyrus | L | −39 | 18 | −21 | 99 | 0.81 | 0.57 |
| Occipital/fusiform/lingual gyrus/cerebellum | L | −24 | −51 | −15 | 94 | 0.83 | 0.55 |
| Negative correlations | |||||||
| Anterior insula/putamen /inferior frontal gyrus/caudate | L | −21 | 18 | −3 | 127 | −0.76 | −0.56 |
Stroop-related neural activity was computed as incongruent >congruent trials. Peak coordinates are reported in Montreal Neurological Institute (MNI) space (x, y, z). Cluster size is in 3 × 3 × 3 mm voxels.
t-tests were computed to assess group differences between cannabis-dependent (N=20) and healthy comparison (N=20) individuals. Results are whole-brain family-wise-error (FWE) corrected for multiple comparisons at p<0.05.
Conjunction analysis of three within-treatment cannabis-abstinence measures that were correlated with pretreatment Stroop-related neural activity in the cannabis-dependent group only (N=20): (1) percent cannabis-negative urines, (2) percent self-reported cannabis-abstinent days during treatment, and (3) maximum self-reported consecutive days of abstinence (Table 1 for group means). All correlations were preformed robustly. Joint conjunction threshold is p<0.000125, with a cluster threshold of 20 voxels.
A whole-brain robust correlation was computed to identify regions where Stroop-related neural activity was associated with long-term treatment outcome, as measured by percent of days of self-reported abstinence at 1-year follow-up. Results are family-wise-error (FWE) corrected for multiple comparisons at p<0.05. Cannabis-dependent individuals with follow-up data available only, N=18.